Company intelligence / Profile preview

Shineco Inc.

Beijing, Beijing Municipality, 中国(China)tianyiluobuma.com ↗
Ownership
Public · SISI
Development stage
Commercial
01

Overview

Shineco has a diversified portfolio with commercialized in vitro diagnostic reagents and medical devices. Its pipeline includes preclinical/early clinical programs in regenerative medicine via its InfiniClone subsidiary and a rapid acting antidepressant natural product through the acquisition of Beijing Wonner Biotech. The company also produces functional foods/nutraceuticals that are already on the market. Clinical results for new therapies are not yet published but development efforts are ongoing

Therapeutic areas
ImmunologyPsychiatryNeurology
Modalities
Stem cells (induced pluripotent stem cell technology)in vitro diagnostic reagentsnatural medicinesnutraceuticals
Industry
Biotech
02

Drug pipeline

1 asset

Luobuma Tea Granules

Unknown
03

Partnerships

Total World Marketing partnership via InfiniClone subsidiary to enter Southeast Asian healthcare market
04

Financials

Market cap
$95.8K
Total revenue
$9.8M
Enterprise value
$11.7M

Beyond the preview

Go deeper on Shineco Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shineco Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call